BIOTECHNOL ADV 润色咨询

BIOTECHNOLOGY ADVANCES

出版年份：1983 年文章数：1629 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：1.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2024-04-17 无敌小宽哥 来自天津

    审稿速度:6.0 | 投稿命中率:5.0
    经验分享：速度慢 还很难

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    引言中是否可以引用非常老的文章？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    引言和讨论的区别？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2020-09-24 wywy19920209

    请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2019-09-06 ms6032332839474392

    审稿速度:3.0
    经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2019-03-21 ms658988217505615

    审稿速度:1.0
    经验分享：请问有中过的前辈知道这个期刊需要约稿吗

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2018-08-02 ms2488033177785606

    审稿速度:1.0
    经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2017-08-02 glassgreen

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2017-07-16 ma_min

    谁能预测这个杂志明年会有多少分?

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2198956, encodeId=019121989560e, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：速度慢 还很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2142329425, createdName=无敌小宽哥, createdTime=Wed Apr 17 14:31:19 CST 2024, time=2024-04-17, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1088043, encodeId=25a81088043b2, content=引言中是否可以引用非常老的文章？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088044, encodeId=14c7108804498, content=引言和讨论的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887980, encodeId=8d8a88e9802c, content=请问elsevier旗下biotechnology advances杂志with editor状态一般持续多久呢？下一个状态是啥？如果被拒一般是多长时间以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2e22054905, createdName=wywy19920209, createdTime=Thu Sep 24 15:37:21 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853612, encodeId=266e85361207, content=审稿速度:3.0<br>经验分享：太难了。审稿意见条条毙命。但期刊真的很不错。大部分需要约稿。需要对所写的领域熟悉透彻。知根知底。不然审稿人不会过关的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Fri Sep 06 14:37:49 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850392, encodeId=9b88850392a5, content=审稿速度:1.0<br>经验分享：请问有中过的前辈知道这个期刊需要约稿吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad75414098, createdName=ms658988217505615, createdTime=Thu Mar 21 17:17:01 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=845835, encodeId=d4f48458353c, content=审稿速度:1.0<br>经验分享：18年3月中旬投稿，4月底给出审稿意见：大修，6月再次投稿，7月底回复接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Thu Aug 02 16:36:00 CST 2018, time=2018-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545024, encodeId=3865545024a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：刚被接收一篇关于皮肤病的，感觉涉及面一定要宽，内容要有一定广度，而机制不要太深入。运气成分是:我们推荐的审稿人有个业内大牛(只能仰视，从未有交集)，编辑也送给他来审，幸运的是他对我们的文章很感兴趣。总体感觉:投biotech adv，文章立题要有针对性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8acb65262, createdName=glassgreen, createdTime=Wed Aug 02 08:57:00 CST 2017, time=2017-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544423, encodeId=6e0a544423a5, content=谁能预测这个杂志明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=ma_min, createdTime=Sun Jul 16 19:10:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836664, encodeId=170a836664ef, content=为什么大家的投稿经验里从来都不分享下投稿费用呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea935414137, createdName=ms8928334115937663, createdTime=Sat May 20 15:34:24 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2017-05-20 ms8928334115937663

    为什么大家的投稿经验里从来都不分享下投稿费用呢？

    0

共18条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分